Lung Cancer Clinical Trial

Clinical Trial Finder Lung Cancer Trials

An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastatic Non Small Cell Lung Carcinoma

See Locations Near You

Summary

The purpose of this study is to predict responses to Erbitux as a single agent in patients with Non Small Cell Lung Cancer

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Measurable disease tumor available for biopsies
Life expectancy of at least 3 months

Exclusion Criteria:

Known or documented brain metastases prior to Cetuximab therapy

Study is for people with:

Lung Cancer

Phase:

Phase 1

Estimated Enrollment:

120

Study ID:

NCT00207116

Recruitment Status:

Completed

Sponsor:

Eli Lilly and Company

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Local Institution
Newark Delaware, , United States

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Phase:

Phase 1

Estimated Enrollment:

120

Study ID:

NCT00207116

Recruitment Status:

Completed

Sponsor:


Eli Lilly and Company

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
Clinical Trials Can be Life-Saving for Some
When Should I Consider Clinical Trials?
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider